Literature DB >> 28185119

Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.

Candice Feben1, Careni Spencer2, Anneline Lochan2, Nakita Laing3, Karen Fieggen3, Engela Honey4, Tasha Wainstein5, Amanda Krause2.   

Abstract

Fanconi anaemia (FA) is a genotypically and phenotypically heterogeneous genetic condition, characterized cytogenetically by chromosomal instability and breakage secondary to impaired DNA repair mechanisms. Affected individuals typically manifest growth restriction and congenital physical abnormalities and most progress to hematological disease including bone marrow aplasia. A rare genetic subtype of FA (FA-D1) is caused by biallelic mutations in the BRCA2 gene. Affected individuals manifest severe congenital anomalies and significant pigmentary changes and are additionally at risk for early onset leukemia and certain solid organ malignancies, including Wilms tumors and brain tumors. Parents of affected individuals are obligate carriers for heterozygous BRCA2 mutations and are thus potentially at risk for adult onset cancers which fall within the hereditary breast and ovarian cancer spectrum. We present two cases of black South African patients with FA diagnosed with biallelic BRCA2 mutations and discuss the phenotypic consequences and implications for them and their families. Recognition of this severe end of the phenotypic spectrum of FA is critical in allowing for confirmation of the diagnosis as well as cascade screening and appropriate care of family members.

Entities:  

Keywords:  BRCA2 mutations; Black South African patients; Cascade screening; Fanconi anaemia; Hereditary breast and ovarian cancer syndrome

Mesh:

Substances:

Year:  2017        PMID: 28185119     DOI: 10.1007/s10689-017-9968-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  20 in total

Review 1.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

2.  A common Fanconi anemia mutation in black populations of sub-Saharan Africa.

Authors:  Neil V Morgan; Fahmida Essop; Ilja Demuth; Thomy de Ravel; Stander Jansen; Marc Tischkowitz; Cathryn M Lewis; Linda Wainwright; Janet Poole; Hans Joenje; Martin Digweed; Amanda Krause; Christopher G Mathew
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

3.  A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa.

Authors:  N C van der Merwe; N Hamel; S-R Schneider; J P Apffelstaedt; J T Wijnen; W D Foulkes
Journal:  Clin Genet       Date:  2011-01-10       Impact factor: 4.438

4.  Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa.

Authors:  A J Tipping; T Pearson; N V Morgan; R A Gibson; L P Kuyt; C Havenga; E Gluckman; H Joenje; T de Ravel; S Jansen; C G Mathew
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

5.  Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.

Authors:  Candice Feben; Jennifer Kromberg; Rosalind Wainwright; David Stones; Janet Poole; Tabitha Haw; Amanda Krause
Journal:  Blood Cells Mol Dis       Date:  2014-11-27       Impact factor: 3.039

6.  Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.

Authors:  Sarah L Sawyer; Lei Tian; Marketta Kähkönen; Jeremy Schwartzentruber; Martin Kircher; Jacek Majewski; David A Dyment; A Micheil Innes; Kym M Boycott; Lisa A Moreau; Jukka S Moilanen; Roger A Greenberg
Journal:  Cancer Discov       Date:  2014-12-03       Impact factor: 39.397

Review 7.  Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling.

Authors:  Stefan Meyer; Marc Tischkowitz; Kate Chandler; Alan Gillespie; Jillian M Birch; D Gareth Evans
Journal:  J Med Genet       Date:  2013-11-20       Impact factor: 6.318

8.  A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51.

Authors:  Najim Ameziane; Patrick May; Anneke Haitjema; Henri J van de Vrugt; Sari E van Rossum-Fikkert; Dejan Ristic; Gareth J Williams; Jesper Balk; Davy Rockx; Hong Li; Martin A Rooimans; Anneke B Oostra; Eunike Velleuer; Ralf Dietrich; Onno B Bleijerveld; A F Maarten Altelaar; Hanne Meijers-Heijboer; Hans Joenje; Gustavo Glusman; Jared Roach; Leroy Hood; David Galas; Claire Wyman; Rudi Balling; Johan den Dunnen; Johan P de Winter; Roland Kanaar; Richard Gelinas; Josephine C Dorsman
Journal:  Nat Commun       Date:  2015-12-18       Impact factor: 14.919

9.  Phenotypic consequences in black South African Fanconi anemia patients homozygous for a founder mutation.

Authors:  Candice Feben; Jennifer Kromberg; Rosalind Wainwright; David Stones; Chris Sutton; Janet Poole; Tabitha Haw; Amanda Krause
Journal:  Genet Med       Date:  2013-10-17       Impact factor: 8.822

10.  BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.

Authors:  F Z Francies; T Wainstein; K De Leeneer; A Cairns; M Murdoch; S Nietz; H Cubasch; B Poppe; T Van Maerken; B Crombez; I Coene; R Kerr; J P Slabbert; A Vral; A Krause; A Baeyens; K B M Claes
Journal:  BMC Cancer       Date:  2015-11-17       Impact factor: 4.430

View more
  4 in total

1.  Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).

Authors:  Lisa J McReynolds; Kajal Biswas; Neelam Giri; Shyam K Sharan; Blanche P Alter
Journal:  Cancer Genet       Date:  2021-10-04

2.  Essential Role of BRCA2 in Ovarian Development and Function.

Authors:  Ariella Weinberg-Shukron; Mariana Rachmiel; Paul Renbaum; Suleyman Gulsuner; Tom Walsh; Orit Lobel; Amatzia Dreifuss; Avital Ben-Moshe; Sharon Zeligson; Reeval Segel; Tikva Shore; Rachel Kalifa; Michal Goldberg; Mary-Claire King; Offer Gerlitz; Ephrat Levy-Lahad; David Zangen
Journal:  N Engl J Med       Date:  2018-09-13       Impact factor: 91.245

3.  Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study.

Authors:  Jaco Oosthuizen; Maritha J Kotze; Nicole Van Der Merwe; Ettienne J Myburgh; Phillip Bester; Nerina C van der Merwe
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

Review 4.  Fanconi Anaemia, Childhood Cancer and the BRCA Genes.

Authors:  Emma R Woodward; Stefan Meyer
Journal:  Genes (Basel)       Date:  2021-09-27       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.